Correlation Between Par Drugs and UTI Asset
Specify exactly 2 symbols:
By analyzing existing cross correlation between Par Drugs And and UTI Asset Management, you can compare the effects of market volatilities on Par Drugs and UTI Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Par Drugs with a short position of UTI Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Par Drugs and UTI Asset.
Diversification Opportunities for Par Drugs and UTI Asset
Very weak diversification
The 3 months correlation between Par and UTI is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Par Drugs And and UTI Asset Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UTI Asset Management and Par Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Par Drugs And are associated (or correlated) with UTI Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UTI Asset Management has no effect on the direction of Par Drugs i.e., Par Drugs and UTI Asset go up and down completely randomly.
Pair Corralation between Par Drugs and UTI Asset
Assuming the 90 days trading horizon Par Drugs And is expected to under-perform the UTI Asset. In addition to that, Par Drugs is 1.04 times more volatile than UTI Asset Management. It trades about -0.09 of its total potential returns per unit of risk. UTI Asset Management is currently generating about 0.14 per unit of volatility. If you would invest 120,305 in UTI Asset Management on August 30, 2024 and sell it today you would earn a total of 9,710 from holding UTI Asset Management or generate 8.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Par Drugs And vs. UTI Asset Management
Performance |
| Timeline |
| Par Drugs And |
| UTI Asset Management |
Par Drugs and UTI Asset Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Par Drugs and UTI Asset
The main advantage of trading using opposite Par Drugs and UTI Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Par Drugs position performs unexpectedly, UTI Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UTI Asset will offset losses from the drop in UTI Asset's long position.| Par Drugs vs. Zee Entertainment Enterprises | Par Drugs vs. HT Media Limited | Par Drugs vs. Unitech Limited | Par Drugs vs. PB Fintech Limited |
| UTI Asset vs. Indian Railway Finance | UTI Asset vs. Cholamandalam Financial Holdings | UTI Asset vs. Reliance Industries Limited | UTI Asset vs. Tata Consultancy Services |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |